Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 90Lung Neoplasms 34Meningeal Carcinomatosis 11Neoplasms 9Neoplasm Metastasis 7Adenocarcinoma of Lung 6Colorectal Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Mesothelioma, Malignant 4Non-squamous Non-small Cell Lung Cancer 3NSCLC 3Mesothelioma 3Carcinoma 3Advanced Solid Tumors 3Non Squamous Non Small Cell Lung Cancer 2Neoplasms by Site 2Neoplasms by Histologic Type 2Carcinoma, Bronchogenic 2Bronchial Neoplasms 2Breast Neoplasms 2Vaccinia 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Small Cell Lung Carcinoma 1Sexual Dysfunction, Physiological 1Sarcoma, Ewing 1Sarcoma 1

Interventions

pembrolizumab 12Cisplatin 7Cetuximab 7Carboplatin 7Docetaxel 6Blood Specimen Collection 4Radiotherapy, Intensity-Modulated 3Paclitaxel 3toripalimab 2atezolizumab 2Radiotherapy 2Nivolumab 2Magnetic Resonance Spectroscopy 2Fluorouracil 2Drug Therapy 2tocilizumab 1regorafenib 1osimertinib 1lenvatinib 1fludarabine 1ficlatuzumab 1cemiplimab 1calcipotriene 1bintrafusp alfa protein, human 1avelumab 1alpha-2'-deoxythioguanosine 1aldesleukin 1aflibercept 1Watchful Waiting 1Vinorelbine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Squamous Cell × Pemetrexed × Clear all
NCT06561685 2026-04-20

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Eli Lilly and Company

Phase 1 Recruiting
340 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡